[Intraglomerular hypertension. Physiopathology and therapeutic implications].
It is now well-established in experimental models in rodents that increased glomerular pressure results in the development of focal and segmental glomerulosclerosis, proteinuria and progressive renal functional deterioration. In humans, direct measurement of glomerular capillary pressure is impossible. However, it is widely accepted that glomerular hypertension is present in different clinical situations, like diabetic nephropathy, chronic renal failure associated with glomerulonephritides, some forms of essential hypertension and cadaveric kidney transplantation. Many studies were performed on the effects of protein-restricted died and/or angiotensin converting enzyme inhibition on the rate of progression of renal failure in these renal diseases. Although controversial, the overall results suggest that these therapeutic strategies may reduce the rate of progression, particularly in diabetic nephropathy.
Mourad
G
G
Service de Néphrologie, Hôpital Lapeyronie, Montpellier.
D000818:Animals; D006801:Humans; D006978:Hypertension, Renovascular / Q000503:physiopathology / Q000628:therapy; D007676:Kidney Failure, Chronic / Q000503:physiopathology / Q000628:therapy; D007678:Kidney Glomerulus / Q000503:physiopathology*; D051381:Rats; D012079:Renal Circulation
L'hypertension intraglomérulaire. Physiopathologie et implications thérapeutiques.